Executive Vice President, Chief Medical Officer and Head of Development

Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA

FDA approves Bristol Myers’ Sotyktu in new indication

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

Why Bristol-Myers Squibb Is a Strong Dividend Stock

0.4444444477558136

Executive Director, Clinical Development Program Lead (Neuropsychiatry)

Bristol Myers Squibb is a global organization dedicated to effective drug development. The Clinical Development Program Leader will set the clinical development strategy, supervise Clinical Development Leads, and work closely with cross-functional teams to ensure successful execution of clinical trials.

President & CEO

Co-founder and lead for PsychU (www.PsychU.org)

Otsuka and Lundbeck receive Complete Response Letter from U.S. FDA for sNDA of REXULTI® (brexpiprazole) in combination with sertraline for the treatment of adults with PTSD

Rare Kidney Disease Community Members Join American Kidney Fund and IgA Nephropathy Foundation on Capitol Hill to Champion Key Legislation

Bipolar Disorder Market Research Report 2025-2035 | Pharma Leaders Advance Bipolar Disorder Treatment with Targeted Therapies and Genomic Innovation

Schizophrenia Market Research and Forecast Report 2025-2034 | Emerging Therapies and Genetic Research Drive Growth with Bristol Myers Squibb, AstraZeneca, and Eli Lilly Leading

Executive Director, Global Clinical Development Program Lead- CNS/Psychiatry

Otsuka Pharmaceutical Companies (U.S.) is a subsidiary focused on global clinical development, seeking an Executive Director to lead their Global Clinical Development Program for CNS/Psychiatry. The role involves overseeing the strategy and execution of clinical development activities for a portfolio of novel serotonergic agonists, ensuring efficient progression towards registration and commercialization while managing stakeholder relationships and governance.

Executive Director and Chief Executive Officer

Group CFO and Executive Director

ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer

Chronic Rhinosinusitis with Nasal Polyps Market Shows Strong Upward Momentum During the Forecast Period (2026-2036) as Demand for Advanced Therapies Rises | DelveInsight

Director/PDMR Shareholding

MSK uncovers how interacting mutations shield breast cancer

0.5555555820465088

Executive Director, Clinical Science and Innovation Lead, Early Oncology Development

AstraZeneca is dedicated to advancing new cancer therapies through its Early Oncology & Precision Medicine division. The Executive Director, Clinical Science for Early Oncology Development will lead a global team of Clinical Scientists, driving innovation and operational excellence to enhance early development strategies across the oncology pipeline.

President and Chief Executive Officer, CVS Health

SVP & CISO

CVS, Humana & More Are Turning to Google’s AI Models

CVS Health launches Health100, Cognito Therapeutics raises $105M, GLP-1 meds might help curb addiction

Google Cloud to showcase how Gemini-powered AI agents are transforming healthcare at HIMSS26

CVS and Google Cloud to launch Health100, an AI-powered health platform

0.3333333432674408

Lead Director, Clinical Strategy Execution

CVS Health is dedicated to building a more connected and compassionate health experience. The Lead Director, Clinical Strategy Execution will lead the development and execution of innovative strategies for emerging mental health conditions, collaborating with various functional leaders to improve outcomes and member satisfaction.

Chief Operating Officer

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed’s Brinsupri wins MHRA approval

Insmed CEO explains 'audacious' $1B projection for 2026 sales of Brinsupri

Breaking Down Insmed: 16 Analysts Share Their Views

Executive Director, Clinical Development - Neurology

Insmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. They are seeking an Executive Director, Clinical Development - Neurology to lead clinical programs, supervise the clinical development team, and play a crucial role in formulating the company’s neurology pipeline and portfolio expansion.

Associate Director, Project Management

Worldwide Clinical Trials Completes Acquisition Of Oncology Specialist Catalyst Clinical Research

Worldwide Clinical Trials Completes Acquisition of Catalyst Clinical Research

Contract Development and Manufacturing Organization (CDMO) Market to Register a Strong CAGR of 9.90% by 2034

North Carolina CROs unite to boost oncology capabilities

Executive Director, Therapeutic Strategy Lead, Neuroscience

Worldwide Clinical Trials is seeking an Executive Director, Therapeutic Strategy Lead, Neuroscience who will serve as a therapeutic consultant and support the sales and customer lifecycle. This cross-functional role involves collaborating with various departments to devise initial development strategies for new business and ensuring effective delivery strategies for clinical trials.

Executive Director, Therapeutic Strategy Lead, Neuroscience - US East Coast - Remote

CEO of Card Services and Connected Commerce

CEO, Morgan Health

The case for scrubbing the seas to save the climate

SoftBank seeks record loan of up to $40 billion for OpenAI stake

True crime, fake romance: Inside one victim's fight with banks

Standard Chartered appoints JP Morgan’s Kinexys co-head to lead payments

Customer Success Executive Director

JPMorganChase, one of the oldest financial institutions, offers innovative financial solutions to millions of consumers and businesses. The Customer Success Executive Director will spearhead transformative success strategies, manage operations and team rhythm, and cultivate lasting customer relationships while overseeing business enablement for IPCS.

Customer Success Executive Director - - COS Lead (Portfolio, RoB, People)

Managing Director, Head of Chase Travel Platform Product

Managing Director, Consumer Bank, General Manager, Growth Financial Products

Chase’s Philadelphia retail head talks banks growth plans, search for affluent-focused financial center

‘Trust me’: Jamie Dimon to defend JP Morgan’s $2bn-a-week bill

Chase details locations of 14 Philadelphia-area branches opening in 2026

Chase to Open More Than 160 Branches in Over 30 States in 2026

Supplier Assessment Operations Onboarding Hub Lead - Executive Director

Chase is a leading financial institution that offers innovative financial solutions to a wide range of clients. The Supplier Assessment Operations Onboarding Hub Lead will oversee a regional team responsible for executing supplier assessments, ensuring critical controls are evaluated, and driving efficient onboarding operations globally.

Chief Human Resources Officer

President

Exploring Revolution Medicines's Earnings Expectations

Cashing In on ‘Creative Fundamentals’ To Fund Rare Disease R&D

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025

StockWatch: C-Suite Shakeup, Phase III Plans Jolt Cardiff Investors

Executive Director, Clinical Supply Chain

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director, Clinical Supply Chain provides strategic leadership and operational oversight for clinical supply chain activities, ensuring efficient processes and compliance with regulatory requirements.

President, CEO & Director (Founder)

Chief Strategy Officer

Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial

Janux Therapeutics reports Q4 EPS (51c), consensus (64c)

Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Janux Therapeutics doses first patient in JANX011 phase 1 trial

Senior/Executive Director, Clinical Pharmacology Lead

Janux Therapeutics is seeking a hands-on, execution-driven Head of Clinical Pharmacology to support the design, analysis, and interpretation of clinical pharmacology strategies across their development programs. This role focuses on executional excellence and strategy, requiring the candidate to produce internal strategic alignment and scientific rigor in deliverables.

Founder, Chief Executive Officer and President

Chief Financial Officer and Executive Vice President, Corporate Strategy

RARE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages RARE Investors with Losses to Contact the Firm

RARE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026

Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE

RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit

Executive Director, US Brand Lead, Neurology

Ultragenyx is a biopharmaceutical company dedicated to advancing the treatment of rare diseases. The Executive Director, US Brand Lead, Neurology Therapeutic Area will lead the US launch of a breakthrough therapy for Angelman Syndrome, overseeing brand strategy and cross-functional collaboration to ensure a successful commercialization.

Strategic Advisor

PANTHERx® Rare Selected by Otsuka to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy

Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight

Systems and methods for treating depression using a digital therapeutic

Use of (1R,5S)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the …

Executive Director, Global Clinical Development Program Lead

Otsuka is a pharmaceutical company that specializes in clinical development and commercialization of health-care products. They are seeking an Executive Director to lead the Global Clinical Development Program for a portfolio of novel serotonergic agonists, overseeing strategy, development, and delivery while ensuring effective collaboration with stakeholders.

Chief Financial Officer

Cantex Continuing Care Network Launches Groundbreaking In-House Blood Transfusion Service

Clinical Branch Leader (Executive Director) Hospice

Cantex is a healthcare organization seeking a Clinical Branch Leader (Executive Director) for their hospice services in Addison, TX. The Executive Director, a licensed Registered Nurse, will lead the branch with a focus on clinical excellence, oversee compliance with regulatory standards, and drive quality assurance initiatives while ensuring high-quality patient care.

Clinical Branch Leader (Executive Director) Hospice (21388)

Founding CTO

Generate IPO raises $400 million but shares sink

Opening Day: Generate Biomedicines makes public debut

TSLP still plays well, Generates $400M IPO

Generate Biomedicines secures $400m IPO in flurry of February listings

Executive Director, Therapeutic Applications & Portfolio Team Lead

Generate:Biomedicines is a pioneering therapeutics company at the intersection of machine learning, biological engineering, and medicine. They are seeking an Executive Director to lead new Therapeutic Applications and serve as a Portfolio Team Lead, focusing on advancing therapeutic applications and leading cross-functional portfolio execution.

Chairman and Chief Executive Officer

Senior Vice President, Legal

'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing

STAT+: Gilead and South Africa are negotiating a license for local production of new HIV drug

Preclinical data support continued testing of Gilead’s HIV candidate GS-3242

Are ACLX, VRE, LSF Obtaining Fair Deals for their Shareholders?

Executive Director, Global Clinical Supply Chain - Oncology

Gilead Sciences is a biopharmaceutical company committed to creating a healthier world by advancing innovative medicines for life-threatening diseases. The Executive Director of Global Clinical Supply Chain will lead the clinical planning function within oncology, inspiring teams and developing strategies to ensure uninterrupted clinical supply for development programs and studies.

SVP, Strategy and Business Development

Director, IRT and Technology Lead

Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor

Alexion Pharmaceuticals discloses C1S inhibitors

AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case

Complement C5 Inhibitors & C5 Receptor Antagonists Pipeline and Competitive Intelligence Report 2025 - ResearchAndMarkets.com

AstraZeneca is committed to advancing cancer therapies through innovative clinical programs. As the Executive Director for Early Oncology Development, you will lead a global team of Clinical Scientists, driving operational excellence and strategic innovation to enhance early development across the oncology pipeline.

Chief Executive Officer

Texas mother of 3-week-old twins fights to protect infants amid growing measles outbreak

Executive Director Supply Chain - Clinical Integration

Covenant Health is seeking an innovative leader for the Executive Director, Supply Chain - Clinical Integration role. This position will champion the strategic vision and leadership for Clinical Value Analysis and optimization of clinical solutions across the supply chain.

Interim Director, Patient Financial Services

Microsoft Research, Providence, and UW develop the GigaTIME AI model, aiming to perform tumor analysis in a fraction of the time and cost of existing methods (Lisa Stiffler/GeekWire)

Providence cutting around 450 positions in Washington, Oregon

Providence teams up with Humana for VBC data exchange

Praia Health, Providence, and Labcorp Collaborate to Transform Patient Engagement and Lab Order Adherence

Providence Health & Services is seeking an innovative visionary for the role of Executive Director Supply Chain - Clinical Integration. This leadership position involves championing the strategic vision and development for Clinical Value Analysis, Conversions, and Consumption Management to enhance clinical processes across the supply chain.

Otsuka Pharmaceutical Companies (U.S.) is a subsidiary focused on global health-care products, seeking an Executive Director for their Global Clinical Development department. The role involves leading the strategy and development of a portfolio of novel serotonergic agonists, ensuring efficient progression toward registration and commercialization while managing internal and external stakeholder relationships.

Executive Director, Clinical Supply Portfolio Lead, Icv And Neuro

Executive Director, Clinical Supply Portfolio Lead, Icv And Neuro in united states (1000+)